<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g)
OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS
UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934
Commission File Number: 1-8350
FRESENIUS USA, INC.
(Exact name of registrant as specified in its charter)
2637 Shadelands Drive, Walnut Creek, California 94598
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (510) 295-0200
Common Stock (par value $.01 per share)
(Title of each class of securities covered by this Form)
Not Applicable
(Titles of all other classes of securities for which a duty to file reports
under section 13(a) or 15(d) remains)
<PAGE> 2
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X ] Rule 12h-3(b)(1)(i) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 15d-6 [ ]
Approximate number of holders of record as of the certification or notice date:
Common Stock: 2
<PAGE> 3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of
1934, Fresenius USA, Inc. has caused this certification/notice to be signed on
its behalf by the undersigned duly authorized person.
DATE: October 2, 1996 FRESENIUS USA, INC.
BY: /s/ Dr. Ben J. Lipps
-------------------------------------
Name: Dr. Ben J. Lipps
Title: President and Chief
Executive Officer
S-1
